Mawatari et al. published a preliminary report entitled “Improvement of Blood Plasmalogens and Clinical Symptoms in Parkinson’s Disease by Oral Administration of Ether Phospholipids: A Preliminary Report” Parkinson’s Disease 2020: 2671070, 2020